PyInvesting

Market research

INDOCO.NSE Indoco Remedies Limited

NSE INR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
20B
P/E ratio
644.68
Analyst target
264
Dividend yield
0.0%
Beta
0.62

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Indoco Remedies Limited is currently in a long term uptrend where the price is trading 46.0% above its 200 day moving average.

From a valuation standpoint, the stock is 54.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.

Indoco Remedies Limited's total revenue rose by 15.3% to $3B since the same quarter in the previous year.

Its net income has increased by 178.7% to $254M since the same quarter in the previous year.

Finally, its free cash flow fell by 54.8% to $245M since the same quarter in the previous year.

Based on the above factors, Indoco Remedies Limited gets an overall score of 4/5.